Industry News
Biotechnology Industry News
Sage’s phase 2 Alzheimer’s drug shows signs of cognitive improvement—but there’s a catch
Sage's phase 2 Alzheimer's drug shows signs of cognitive improvement—but there's a catch aarmstrong Fri, 04/01/2022 - 09:33
With 2023 launch in sight, Pharming shares pivotal data on ex-Novartis rare disease drug
With 2023 launch in sight, Pharming shares pivotal data on ex-Novartis rare disease drug ntaylor Fri, 04/01/2022 - 08:03
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism ntaylor Fri, 04/01/2022 - 06:49
Layoff surge hits 3 more biotech companies
Layoff surge hits 3 more biotech companies gmasson Thu, 03/31/2022 - 18:08
Fierce Biotech Layoff Tracker: Novartis, bluebird add to pile of 30-plus biotechs laying off staff
Fierce Biotech Layoff Tracker: Novartis, bluebird add to pile of 30-plus biotechs laying off staff aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Kaleido closes up shop, Akebia cuts 42% of workforce
Fierce Biotech Layoff Tracker: Kaleido closes up shop, Akebia cuts 42% of workforce aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: ProQR ousts 30% of staff after phase 2/3 setback, cuts across medtech
Fierce Biotech Layoff Tracker: ProQR ousts 30% of staff after phase 2/3 setback, cuts across medtech aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Layoffs hit small biotechs Finch, Imara
Fierce Biotech Layoff Tracker: Layoffs hit small biotechs Finch, Imara aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Judgement day for Nektar; SolidBio makes cuts
Fierce Biotech Layoff Tracker: Judgement day for Nektar; SolidBio makes cuts aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Spero cuts workforce after tough FDA call, Genocea crumbles
Fierce Biotech Layoff Tracker: Spero cuts workforce after tough FDA call, Genocea crumbles aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Agios slims R&D operations, Spero cuts after tough FDA call
Fierce Biotech Layoff Tracker: Agios slims R&D operations, Spero cuts after tough FDA call aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Agios slims R&D operations, Scholar Rock in a hard place
Fierce Biotech Layoff Tracker: Agios slims R&D operations, Scholar Rock in a hard place aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Genocea closes up shop, Applied axes 40% of staff
Fierce Biotech Layoff Tracker: Genocea closes up shop, Applied axes 40% of staff aarmstrong Thu, 03/31/2022 - 16:21
Fierce Biotech Layoff Tracker: Atreca culls workforce in reorganization; Genocea closes up shop
Fierce Biotech Layoff Tracker: Atreca culls workforce in reorganization; Genocea closes up shop aarmstrong Thu, 03/31/2022 - 16:21
Chutes & Ladders—John Mascola departs NIAID’s Vaccine Research Center after 22 years
Chutes & Ladders—John Mascola departs NIAID's Vaccine Research Center after 22 years mbayer Thu, 03/31/2022 - 14:34
Vertex gets proof-of-concept for non-opioid painkiller, clearing way for pivotal studies
Vertex gets proof-of-concept for non-opioid painkiller, clearing way for pivotal studies aarmstrong Thu, 03/31/2022 - 10:59
Reuniting the band: Former Merck CEO follows 3 former colleagues to Eikon
Reuniting the band: Former Merck CEO follows 3 former colleagues to Eikon mbayer Thu, 03/31/2022 - 09:38
Taysha lays off 35% of staff, narrows R&D focus to keep funding its top gene therapies
Taysha lays off 35% of staff, narrows R&D focus to keep funding its top gene therapies ntaylor Thu, 03/31/2022 - 08:00
Ono pulls trigger on deal for multispecific antibody against ‘very challenging’ cancer target
Ono pulls trigger on deal for multispecific antibody against 'very challenging' cancer target ntaylor Thu, 03/31/2022 - 06:39
CytoDyn’s leronlimab slapped with FDA holds for COVID-19, HIV programs
CytoDyn's leronlimab slapped with FDA holds for COVID-19, HIV programs aarmstrong Wed, 03/30/2022 - 17:50